Cytiva

Explore

  • Applications
    • Bioprocessing
    • Cell and Gene Therapy
    • Cellular Analysis
    • Diagnostics
    • Emerging Biotech
    • Enterprise Solutions
    • Genomics
    • Lab Filtration
    • Protein Research
  • Products
  • Service & Support
  • Our Company
    • About Us
    • Our Brands
    • News Center
    • Careers
    • Biopharma Resilience Index
  • {{main.productCount}} {{main.productCount}}
    Your Cart
    Showing {{main.getNumberOfShowingResults(main.products)}} of {{main.products.length}} items

    You don't have any items in your cart yet.

    {{item.qty}} x {{item.productName}} Product Code: {{item.catalogCode}} Pack Size: {{item.packSize}} Price: {{item.price}} {{item.unitPrice}} {{item.currency}}
    Subtotal
    {{main.subtotal}} {{main.currency}}
    Checkout now
Bioprocessing
  • Products & solutions
    • Upstream Bioprocessing
    • Downstream Bioprocessing
    • Enterprise Solutions
    • Single-use Solutions
    • Security of Supply
    • Biomanufacturing Solutions
    • Process Intensification
    • Automation and Digital Solutions
  • Services
    • Biomanufacturing Services
    • Process Development Services
    • Custom Services
    • Bioprocess Training and Education
    • Testa Innovation Center
    • Process Validation Services
  • Knowledge center
  • Blog & news
  • Events

Please change the country on your profile in order to switch to another country store.

Edit Profile

CDMO services speed biologics to clinical trials faster

Complement your long-term biomanufacturing strategy

Deciding when outsourcing makes sense

If your business strategy doesn’t fully align with your organization’s capabilities in terms of expertise, capacity, and resources, it might be wise to consider outsourcing to a biologics CDMO for speed to market.

“To facilitate the speed of clinical process development, we had to assess how this approach would affect our project timeline and then look at strategies to shorten the R&D phase.”

Chris Rode, Scientific Director at Janssen 
Pharmaceuticals/Discovery, Product Development & Supply

Contact Us

Choosing the right CDMO

Leveraging service support externally might feel risky when you want to maintain ownership and control over your process outcome, or if you need to protect your intellectual property in new markets. There are five key qualities that you should look for in your CDMO partner, three are sometimes overlooked.

Fast Trak Capabilities

Parallel operations in biopharma manufacturing

Being honest with yourself about what internal capabilities exist and whether the necessary skills and resources are available in-house to deliver on time can help avoid major failures and/or a longer lead time to market.

Read this to decide whether you should double up with a CDMO to reduce risk.

Relationship is everything

Work with a company who fills the gaps in your organization and enhances, rather than replaces, your internal expertise. Ask your CDMO if they offer:

  • A one team approach: allowing persons in plant
  • Process security: do you trust process details to be shared openly
  • Documentation rigor: best practices for optimal communications

Is your biologics CDMO transparent?

Contact Us

Contact our Fast Trak team for more information on our CDMO services.

Something went wrong!
Thank you!
  • United States
Applications
  • Bioprocessing
  • Cell and Gene Therapy
  • Cellular Analysis
  • Enterprise Solutions
  • Genomics
  • Lab Filtration
  • Protein Research
Shop
  • Special offers
  • Find a distributor
  • Order status
  • Register with us
  • Shipping information
  • Returns
Our Company
  • About us
  • News center
  • Careers
  • Sustainability
  • Events
Support
  • Support
  • Contact us
  • Regulatory
  • Certificates
  • Handbooks
  • Safety Data Sheets/SDS
  • Tools and calculators
  • Training
© 2021 Cytiva TermsPrivacyManage CookiesTrademarksPreferences